ArticleTargeted oncology2021

Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Rachel Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.